Vanguard Personalized Indexing Management
LXEO icon

Vanguard Personalized Indexing Management’s Lexeo Therapeutics LXEO Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.6K Buy
19,466
+1,901
+11% +$10.3K ﹤0.01% 2065
2026
Q1 		$101K Buy
17,565
+1,129
+7% +$8K ﹤0.01% 1946
2025
Q4 		$163K Sell
16,436
-159
-1% -$1.45K ﹤0.01% 1755
2025
Q3 		$110K Buy
16,595
+1,595
+11% +$7.71K ﹤0.01% 1806
2025
Q2 		$60.3K Buy
+15,000
New +$49.3K ﹤0.01% 1802

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Personalized Indexing Management's LXEO Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Lexeo Therapeutics (LXEO) stake by 11% in Q2 2026, buying an estimated $10.3K and bringing the position to 19,466 shares worth $90.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

Vanguard Personalized Indexing Management first reported a position in LXEO in Q2 2025 and has held it in 5 quarters since. The position peaked at $163K in Q4 2025. 142 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Vanguard Personalized Indexing Management held 19,466 shares of Lexeo Therapeutics worth $90.6K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 1,901 Lexeo Therapeutics shares in Q2 2026, an estimated $10.3K.
  • Lexeo Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2065 holding.
  • Vanguard Personalized Indexing Management first reported a position in Lexeo Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Vanguard Personalized Indexing Management's Lexeo Therapeutics position peaked at $163K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.